PURPOSE: To investigate the possibility of increasing elution of fosfomycin, gentamicin, clindamycin, and vancomycin by the addition of dextran fluid during the cement-mixing phase. METHODS: In 12 test series, we produced standardized, antibiotic-loaded test specimens of cement, with and without addition of dextran, and determined their effectiveness against three reference pathogens in agar diffusion and elution tests. RESULTS: In the test series using combined agents, Refobacin(®)-Palacos(®)R plus fosfomycin continuously produced the largest zone of inhibition, both against methicillin-sensitive Staphylococcus aureus (p = 0.009) and against methicillin-resistant Staphylococcus aureus (p = 0.009). The addition of dextran to the various test series had no useful effect on the size of the zone of inhibition for any of the antibiotics tested. CONCLUSIONS: Dextran supplementation in Refobacin(®)-Palacos(®)R bone cement did not have the hope for positive effect on the elution rate of bound antibiotics.
PURPOSE: To investigate the possibility of increasing elution of fosfomycin, gentamicin, clindamycin, and vancomycin by the addition of dextran fluid during the cement-mixing phase. METHODS: In 12 test series, we produced standardized, antibiotic-loaded test specimens of cement, with and without addition of dextran, and determined their effectiveness against three reference pathogens in agar diffusion and elution tests. RESULTS: In the test series using combined agents, Refobacin(®)-Palacos(®)R plus fosfomycin continuously produced the largest zone of inhibition, both against methicillin-sensitive Staphylococcus aureus (p = 0.009) and against methicillin-resistant Staphylococcus aureus (p = 0.009). The addition of dextran to the various test series had no useful effect on the size of the zone of inhibition for any of the antibiotics tested. CONCLUSIONS:Dextran supplementation in Refobacin(®)-Palacos(®)R bone cement did not have the hope for positive effect on the elution rate of bound antibiotics.
Authors: Konstantinos Anagnostakos; Jens Kelm; Thilo Regitz; Eduard Schmitt; Werner Jung Journal: J Biomed Mater Res B Appl Biomater Date: 2005-02-15 Impact factor: 3.368
Authors: Daniëlle Neut; Otto S Kluin; Jonathan Thompson; Henny C van der Mei; Henk J Busscher Journal: BMC Musculoskelet Disord Date: 2010-11-10 Impact factor: 2.362
Authors: Omid Shahpari; Alireza Mousavian; Nafise Elahpour; Michael-Alexander Malahias; Mohammad H Ebrahimzadeh; Ali Moradi Journal: Arch Bone Jt Surg Date: 2020-01
Authors: Sigrun Eick; Kevin Hofpeter; Anton Sculean; Claudia Ender; Susann Klimas; Sebastian Vogt; Sandor Nietzsche Journal: Biomed Res Int Date: 2017-04-06 Impact factor: 3.411
Authors: Annett Klinder; Sarah Zaatreh; Martin Ellenrieder; Sylvio Redanz; Andreas Podbielski; Tobias Reichel; Hans Bösebeck; Wolfram Mittelmeier; Rainer Bader Journal: J Biomed Mater Res B Appl Biomater Date: 2018-10-12 Impact factor: 3.368